Jump to content

Vitamin B12 deficiency

From Wikipedia, the free encyclopedia
(Redirected from B12 deficiency)

Vitamin B12 deficiency
Other namesHypocobalaminemia, cobalamin deficiency
Image of the cervical spinal cord in vitamin B12 deficiency showing subacute combined degeneration. (A) The midsagittal T2 weighted image shows linear hyperintensity in the posterior portion of the cervical tract of the spinal cord (black arrows). (B) Axial T2 weighted images reveal the selective involvement of the posterior columns.
SpecialtyNeurology, hematology
SymptomsDecreased ability to think, feeling tired, depression, irritability, abnormal sensations, changes in reflexes[1]
ComplicationsMegaloblastic anemia, irreversible damage to the brain and nervous system[2]
CausesPoor absorption, decreased intake, increased requirements[1]
Diagnostic methodBlood levels below 148–185 pmol/L (200–250 pg/mL) in adults[2]
PreventionSupplementation in those at high risk[2]
TreatmentSupplementation by mouth or injection[3]
Frequency6% (< 60 years old), 20% (> 60 years old)[4]

Vitamin B12 deficiency, also known as cobalamin deficiency, is the medical condition in which the blood and tissue have a lower than normal level of vitamin B12.[5] Symptoms can vary from none to severe.[1] Mild deficiency may have few or absent symptoms.[1] In moderate deficiency, feeling tired, headaches, soreness of the tongue, mouth ulcers, breathlessness, feeling faint, rapid heartbeat, low blood pressure, pallor, hair loss, decreased ability to think and severe joint pain and the beginning of neurological symptoms, including abnormal sensations such as pins and needles, numbness and tinnitus may occur.[1] Severe deficiency may include symptoms of reduced heart function as well as more severe neurological symptoms, including changes in reflexes, poor muscle function, memory problems, blurred vision, irritability, ataxia, decreased smell and taste, decreased level of consciousness, depression, anxiety, guilt and psychosis.[1] If left untreated, some of these changes can become permanent.[1][6] Temporary infertility, reversible with treatment, may occur.[1][7] A late finding type of anemia known as megaloblastic anemia is often but not always present.[2] In exclusively breastfed infants of vegan mothers, undetected and untreated deficiency can lead to poor growth, poor development, and difficulties with movement.[2]

Causes are usually related to conditions that give rise to malabsorption of vitamin B12 particularly autoimmune gastritis in pernicious anemia.[8] Other conditions giving rise to malabsorption include surgical removal of the stomach, chronic inflammation of the pancreas, intestinal parasites, certain medications such as long-term use of proton pump inhibitors, H2-receptor blockers, and metformin, and some genetic disorders.[1][9] Deficiency can also be caused by inadequate dietary intake such as with the diets of vegetarians, and vegans, and in the malnourished.[1] Deficiency may be caused by increased needs of the body for example in those with HIV/AIDS, and shortened red blood cell lifespan.[1] Diagnosis is typically based on blood levels of vitamin B12 below 148–185 pmol/L (200 to 250 pg/mL) in adults.[2] Diagnosis is not always straightforward as serum levels can be falsely high or normal.[10] Elevated methylmalonic acid levels may also indicate a deficiency.[2] Individuals with low or marginal values of vitamin B12 in the range of 148–221 pmol/L (200–300 pg/mL) may not have classic neurological or hematological signs or symptoms.[2]

Treatment is by vitamin B12 supplementation, either by mouth or by injection.[3] Initially in high daily doses, followed by less frequent lower doses, as the condition improves.[3] If a reversible cause is found, that cause should be corrected if possible.[11] If no reversible cause is found, or when found it cannot be eliminated, lifelong vitamin B12 administration is usually recommended.[12] A nasal spray is also available.[2] Vitamin B12 deficiency is preventable with supplements, which are recommended for pregnant vegetarians and vegans, and not harmful in others.[2] Risk of toxicity due to vitamin B12 is low.[2]

Vitamin B12 deficiency in the US and the UK is estimated to occur in about 6 percent of those under the age of 60, and 20 percent of those over the age of 60.[4] In Latin America, about 40 percent are estimated to be affected, and this may be as high as 80 percent in parts of Africa and Asia.[1] Marginal deficiency is much more common and may occur in up to 40% of Western populations.[2]

Signs, symptoms and complications

[edit]
Possible oral manifestation of B12 deficiency: erythema and depapillation of the tongue in a patient. From Kim et al., 2016.[13]

Vitamin B12 deficiency appears slowly and worsens over time, and can often be confused with other conditions.[14] It may often go unrecognized, as the body becomes used to feeling unwell.

Vitamin B12 deficiency can lead to anemia, neurologic, and digestive dysfunctions.[15][16][17] A mild deficiency may not cause any discernible symptoms, but at levels moderately lower than normal, a range of symptoms such as feeling tired, weak, lightheadedness, headaches, dizziness, rapid breathing, rapid heartbeat, cold hands and feet, low-grade fevers, tremor, cold intolerance, easy bruising and bleeding, pale skin, low blood pressure, sore tongue, upset stomach, loss of appetite, weight loss, constipation, diarrhea, severe joint pain, feeling abnormal sensations including numbness or tingling (pins and needles) to the fingers and toes, and tinnitus, may be experienced.[18][19][20][21] A wide range of associated symptoms may include angular cheilitis, mouth ulcers, bleeding gums, hair loss and thinning, premature greying, a look of exhaustion and dark circles around the eyes, as well as brittle nails.[6]

Severe vitamin B12 deficiency can damage nerve cells.[7] If this happens, vitamin B12 deficiency may result in sense loss, loss of sensation in the feet, difficulty walking, poor balance, blurred vision, changes in reflexes, muscle weakness, decreased smell and taste, decreased level of consciousness, mood changes, memory loss, depression, irritability, anxiety, clumsiness, disorientation, psychosis and, in severe cases, dementia.[22][23] Tissue deficiencies may negatively affect nerve cells, bone marrow, and the skin.[5]

A further complication of severe deficiency is the neurological complex known as subacute combined degeneration of spinal cord.[24][25] also myelosis funicularis,[26] or funicular myelosis.[25] This complex consists of the following symptoms:

  1. Impaired perception of deep touch, pressure and vibration, loss of sense of touch, very annoying and persistent paresthesias
  2. Ataxia of dorsal column type
  3. Decrease or loss of deep muscle-tendon reflexes
  4. Pathological reflexes – Babinski, Rossolimo and others, also severe paresis.

The presence of peripheral sensory-motor symptoms or subacute combined degeneration of spinal cord strongly suggests the presence of a B12 deficiency instead of folate deficiency. Methylmalonic acid, if not properly handled by B12, remains in the myelin sheath, causing fragility. Dementia and depression have been associated with this deficiency as well, possibly from the under-production of methionine because of the inability to convert homocysteine into this product. Methionine is a necessary cofactor in the production of several neurotransmitters. Each of those symptoms can occur either alone or with others. Vitamin B12 is essential for the development of the brain. Its deficiency can cause neurodevelopmental problems which can be partly reversible with early treatment.[27] Only a small subset of dementia cases have been found to be reversible with vitamin B12 therapy.[28] Tinnitus may be associated with vitamin B12 deficiency.[29]

Vitamin B12 deficiency may accompany certain eating disorders or restrictive diets.[30]

Pernicious anemia

[edit]

Pernicious anemia is a disease caused by an autoimmune response that produces antibodies that attack the parietal cells in the stomach lining, preventing them from creating intrinsic factor needed for the absorption of vitamin B12.[1][2] It is the main and most common cause of vitamin B12 deficiency anemia in developed countries,[2] and is characterized by a triad of symptoms:

  1. Anemia with bone marrow promegaloblastosis (megaloblastic anemia). This is due to the inhibition of DNA synthesis (specifically purines and thymidine).
  2. Gastrointestinal symptoms: alteration in bowel motility, such as mild diarrhea or constipation, and loss of bladder or bowel control.[31] These may be due to defective DNA synthesis inhibiting replication in a site with a high turnover of cells. This may also result from the autoimmune attack on parietal cells of the stomach. There is an association with "watermelon stomach" (GAVE) and pernicious anemia.[32][33]
  3. Neurological symptoms: Sensory or motor deficiencies (absent reflexes, diminished vibration or soft touch sensation), subacute combined degeneration of spinal cord, or seizures.[34][35] Deficiency symptoms in children include developmental delay, regression, irritability, involuntary movements, and hypotonia.[36]

In babies, neurological symptoms can occur from malnutrition or pernicious anemia in the mother. These include poor growth, apathy, having no desire for food, and developmental regression. While most symptoms resolve with supplementation, some developmental and cognitive problems may persist.[37]

Metabolic risk in offspring

[edit]

Vitamin B12 is a critical micronutrient essential for supporting the increasing metabolic demands of the foetus during pregnancy.[38] B12 deficiency in pregnant women is increasingly common[39] and has been shown to be associated with major maternal health implications, including increased obesity,[39] higher body mass index (BMI),[40] insulin resistance,[38] gestational diabetes, and type 2 diabetes (T2D) in later life.[41] A study in a pregnant white non-diabetic population in England, found that for every 1% increase in BMI, there was 0.6% decrease in circulating B12.[38] Furthermore, an animal study in ewes demonstrated that a B12, folate and methionine restricted diet around conception, resulted in offspring with higher adiposity, blood pressure and insulin resistance which could be accounted for by altered DNA methylation patterns.[42]

Both vitamin B12 and folate are involved in the one-carbon metabolism cycle. In this cycle, vitamin B12 is a necessary cofactor for methionine synthase, an enzyme involved in the methylation of homocysteine to methionine.[43] DNA methylation is involved in the functioning of genes and is an essential epigenetic control mechanism in mammals. This methylation is dependent on methyl donors such as vitamin B12 from the diet.[44] Vitamin B12 deficiency has the potential to influence methylation patterns in DNA, besides other epigenetic modulators such as micro (RNAs), leading to the altered expression of genes.[45][46] Consequently, an altered gene expression can possibly mediate impaired foetal growth and the programming of non-communicable diseases.[47][45]

Vitamin B12 and folate status during pregnancy is associated with the increasing risk of low birth weight,[39][48] preterm birth,[48] insulin resistance and obesity[38][40] in the offspring. In addition it has been associated with adverse foetal and neonatal outcomes including neural tube defects (NTDs)[49][50][51][52] and delayed myelination or demyelination.[37][53] The mother's B12 status can be important in determining the later health of the child, as shown in the Pune maternal Nutrition Study, conducted in India. In this study, children born to mothers with high folate concentrations and low vitamin B12 concentrations were found to have higher adiposity and insulin resistance at age 6. In the same study, over 60% of pregnant women were deficient in vitamin B12, which was considered to increase the risk of gestational and later diabetes in the mothers.[40] Increased longitudinal cohort studies or randomised controlled trials are required to understand the mechanisms between vitamin B12 and metabolic outcomes, and to potentially offer interventions to improve maternal and offspring health.[54]

Cardiometabolic disease outcomes

[edit]

Multiple studies have explored the association between vitamin B12 and metabolic disease outcomes, such as obesity, insulin resistance and the development of cardiovascular disease.[55][56][57] A long-term study where vitamin B12 was supplemented across a period of 10 years, led to lower levels of weight gain in overweight or obese individuals (p < 0.05).[58]

There are several mechanisms which may explain the relationship between obesity and decreased vitamin B12 status. Vitamin B12 is a major dietary methyl donor, involved in the one-carbon cycle of metabolism and a recent genome-wide association (GWA) analysis showed that increased DNA methylation is associated with increased BMI in adults,[59] consequently a deficiency of vitamin B12 may disrupt DNA methylation and increase non-communicable disease risk. Vitamin B12 is also a co-enzyme which converts methylmalonyl-CoA to succinyl-CoA in the one carbon cycle. If this reaction cannot occur, methylmalonyl-CoA levels elevate, inhibiting the rate-limiting enzyme of fatty acid oxidation (CPT1 – carnitine palmitoyl transferase), leading to lipogenesis and insulin resistance.[60] Further to this, reduced vitamin B12 concentrations in the obese population is thought to result from repetitive short-term restrictive diets and increased vitamin B12 requirements secondary to increased growth and body surface area.[55][61] It has also been hypothesised that low vitamin B12 concentrations in obese individuals are a result of wrong feeding habits, where individuals consume a diet low in micronutrient density.[62] Finally, vitamin B12 is involved in the production of red blood cells, and vitamin B12 deficiency can result in anemia, which causes fatigue and the lack of motivation to exercise.[58]

The investigation into the relationship between cardiovascular disease (CVD) and vitamin B12 has been limited, and there is still controversy as to whether primary intervention with vitamin B12 will lower cardiovascular disease.[63] Deficiency of vitamin B12 can impair the remethylation of homocysteine in the methionine cycle, and result in raised homocysteine levels.[64] There is much evidence linking elevated homocysteine concentrations with an increased risk of cardiovascular disease,[65] and homocysteine lowering treatments have led to improvements in cardiovascular reactivity and coagulation factors.[66] In adults with metabolic syndrome, individuals with low levels of vitamin B12 had higher levels of homocysteine compared to healthy subjects.[67] It is thus possible that vitamin B12 deficiency enhances the risk of developing cardiovascular disease in individuals who are obese.[55] Alternatively, low levels of vitamin B12 may increase the levels of proinflammatory proteins which may induce ischaemic stroke.[68][69]

It is important to screen vitamin B12 deficiency in obese individuals, due to its importance in energy metabolism, and relationship with homocysteine and its potential to modulate weight gain.[62] More studies are needed to test for the causality of vitamin B12 and obesity using genetic markers.[70] A few studies have also reported no deficiency of vitamin B12 in obese individuals.[71][72][73][74] Finally, a recent literature review conducted over 19 studies, found no evidence of an inverse association between BMI and circulating vitamin B12.[70]

Previous clinical and population-based studies have indicated that vitamin B12 deficiency is prevalent amongst adults with type 2 diabetes.[75][76] Kaya et al., conducted a study in women with polycystic ovary syndrome, and found that obese women with insulin resistance had lower vitamin B12 concentrations compared to those without insulin resistance.[77] Similarly, in a study conducted in European adolescents, there was an association between high adiposity and higher insulin sensitivity with vitamin B12 concentrations. Individuals with a higher fat mass index and higher insulin sensitivity (high Homeostatic Model Assessment [HOMA] index) had lower plasma vitamin B12 concentrations.[78] Furthermore, a recent study conducted in India reported that mean levels of vitamin B12 decreased with increasing levels of glucose tolerance e.g. individuals with type 2 diabetes had the lowest values of vitamin B12, followed by individuals with pre-diabetes and normal glucose tolerance, respectively.[79] However, B12 levels of middle aged-women with and without metabolic syndrome[80] showed no difference in vitamin B12 levels between those with insulin resistance (IR) and those without. It is believed that malabsorption of vitamin B12 in diabetic patients, is due to individuals taking metformin therapy (an insulin sensitizer used for treating type 2 diabetes).[81] Furthermore, obese individuals with type 2 diabetes are likely to develop gastroesophageal reflux disease,[82] and take proton pump inhibitors, which further increased the risk of vitamin B12 deficiency.[70]

A literature review conducted in 2011 over seven studies, found that there was limited evidence to show that low vitamin B12 status increased the risk of cardiovascular disease and diabetes.[83] However, the review did not identify any associations between vitamin B12 and cardiovascular disease in the remaining four studies.[83] Currently, no data supports vitamin B12 supplementation on reducing the risk of cardiovascular disease. In a dose-response meta-analysis of five prospective cohort studies, it was reported that the risk of coronary heart disease (CHD) did not change substantially with increasing dietary vitamin B12 intake.[84] Of these five studies, three of the studies stated a non-significant positive association and two of the studies demonstrated an inverse association between vitamin B12 supplementation and coronary heart disease (only one of the studies was significant).[84]

Anemia

[edit]

Vitamin B12 deficiency is one of the main causes of anemia.[16] In countries where B12 deficiency is common, it is generally assumed that there is a greater risk of developing anemia. However, the overall contribution of vitamin B12 deficiency to the global incidence of anemia may not be significant, except in elderly individuals, vegetarians, cases of malabsorption and some genetic disorders.[85] Anemia is defined as a condition in which there are not enough red blood cells, as the tissues and organs of the body do not get enough oxygen. Megaloblastic anemia caused by vitamin B12 deficiency is characterized by red blood cells that are larger than normal and are unable to deliver oxygen to the body's organs.[7][8] The clinical case indicates an altered synthesis of DNA, in which vitamin B12 is essential for the production and maturation of red blood cells in the bone marrow.[8] Adult patients often report to medical attention symptoms related to anemia, such as feeling tired and weak, breathlessness, exercise intolerance, feeling faint, headaches, paleness, dry lips and a disturbance of taste.[8]

Pernicious anemia is the most common cause of vitamin B12 deficiency anemia in adults, which results from malabsorption of vitamin B12 due to a lack or loss of intrinsic factor.[2][8] There are relatively few studies which have assessed the impact of haematological measures in response to B12 supplementation. One study in 184 premature infants, reported that individuals given monthly vitamin B12 injections (100 μg) or taking supplements of vitamin B12 and folic acid (100 μg/day), had higher haemoglobin concentrations after 10–12 weeks, compared to those only taking folic acid or those taking no vitamin B12 injections.[86] In deficient Mexican adult women and pre-schoolers, it was found that vitamin B12 supplementation did not affect any haematologic parameters.[87][88]

Aging

[edit]

In the elderly, vitamin B12 deficiency has been associated with the development of macular degeneration, and the risk of frailty.[89] Macular degeneration is the leading cause of severe, irreversible vision loss in older adults.[90][91] Several risk factors have been linked to macular degeneration, including family history, genetics, hypercholesterolemia, hypertension, sunlight exposure and lifestyle (smoking and diet).[92][93][94] It has been shown that daily supplementation of vitamin B12, B6 and folate over a period of seven years can reduce the risk of age-related macular degeneration by 34% in women with increased risk of vascular disease (n=5,204).[95] However, another study failed to find an association between age-related macular degeneration and vitamin B12 status in a sample of 3,828 individuals representative of the non-institutionalized US population.[96]

Frailty is a geriatric condition which is characterized by diminished endurance, strength, and reduced physiological function that increases an individual's risk of mortality and impairs an individual from fulfilling an independent lifestyle.[97] Frailty is associated with an increased vulnerability to fractures, falls from heights, reduced cognitive function and more frequent hospitalisation.[98] The worldwide prevalence of frailty within the geriatric population is 13.9%,[99] therefore there is an urgent need to eliminate any risk factors associated with frailty. Poor vitamin B status has been shown to be associated with an increased risk of frailty. Two cross sectional studies have reported that deficiencies of vitamin B12 were associated with the length of hospital stay, as observed by serum vitamin B12 concentrations and methylmalonic acid (MMA) concentrations.[100] Furthermore, another study of elderly women, found that certain genetic variants associated with vitamin B12 status (tanscobalamin II) may contribute to reduced energy metabolism, consequently contributing to frailty.[101] Given that there are limited studies assessing the relationship between vitamin B12 and frailty status, more longitudinal studies are needed to clarify the relationship.

Neurological decline

[edit]

Severe vitamin B12 deficiency is associated with subacute combined degeneration of the spinal cord, which involves demyelination of the posterior and lateral columns of the spinal cord.[102] Symptoms include memory and cognitive impairment, sensory loss, motor disturbances, personality changes, disorientation, irritability, dementia, loss of posterior column functions and disturbances in proprioception.[103][104][105] In advanced stages of vitamin B12 deficiency, cases of psychosis, paranoia and severe depression have been observed, which may lead to permanent disability if left untreated.[102][103][104] Studies have shown the rapid reversal of the neurological symptoms of vitamin B12 deficiency, after treatment with high-dose of vitamin B12 supplementation; suggesting the importance of prompt treatment in reversing neurological manifestations.[106]

Cognitive decline

[edit]

Elderly individuals are currently assessed on vitamin B12 status during the screening process for dementia. Studies investigating the association between vitamin B12 concentrations and cognitive status have produced inconclusive results.[89][107][108] It has been shown that elevated MMA concentrations are associated with decreased cognitive decline and Alzheimer's disease.[109] In addition, low vitamin B12 and folate intakes have shown associations with hyperhomocysteinemia, which is associated with cerebrovascular disease, cognitive decline and an increased risk of dementia in prospective studies.[110]

There are limited intervention studies which have investigated the effect of supplementation of vitamin B12 and cognitive function. A Cochrane review, analysing two studies, found no effect of vitamin B12 supplementation on the cognitive scores of older adults.[111][needs update] A recent longitudinal study in elderly individuals, found that individuals had a higher risk of brain volume loss over a 5-year period, if they had lower vitamin B12 and holoTC levels and higher plasma tHcy and MMA levels.[112] More intervention studies are needed to determine the modifiable effects of vitamin B12 supplementation on cognition.[89]

Osteoporosis

[edit]

There has been growing interest on the effect of low serum vitamin B12 concentrations on bone health.[113][114] Studies have found a connection between elevated plasma tHcy and an increased risk of bone fractures, but is unknown whether this is related to the increased levels of tHcy or to vitamin B12 levels (which are involved in homocysteine metabolism).[115] Results from the third NHANES conducted in the United States, found that individuals had significantly lower bone mass density (BMD) and higher osteoporosis rates with each higher quartile of serum MMA (n= 737 men and 813 women).[116] Given that poor bone mineralization has been found in individuals with pernicious anemia,[117] and that the content of vitamin B12 within bone cells in culture has shown to affect the functioning of bone forming cells (osteoblasts);[118] it is possible that vitamin B12 deficiency is causally related to poor bone health.

Randomized intervention trials investigating the association of vitamin B12 supplementation and bone health have yielded mixed results. One study conducted on osteoporotic risk patients with hyperhomocysteinemia found positive effects between supplementation of B vitamins on BMD.[119] However, no improvement in BMD was observed in a group of healthy older people.[120] Further, controlled trials are needed to confirm the impact and mechanisms vitamin B12 deficiency has on bone mineralization.[121]

Causes

[edit]

Vitamin B12 deficiency can be caused by impaired absorption, inadequate dietary intake, or increased requirements.[1] Impaired absorption explains most cases of vitamin B12 deficiency, but it can also result from other factors.[2]

Impaired absorption

[edit]

Inadequate intake

[edit]

Vitamin B12 cannot be produced by the human body, and must be obtained from the diet.[2] The body normally gets enough vitamin B12 from the consumption of foods from animal sources.[2] Inadequate dietary intake of animal products such as eggs, meat, milk, fish, fowl (and some type of edible algae) can result in a deficiency state.[134] Vegans, and to a lesser degree vegetarians, are at risk for B12 deficiency if they do not consume either a dietary supplement or vitamin-fortified foods. Children are at a higher risk for B12 deficiency due to inadequate dietary intake, as they have fewer vitamin stores and a relatively larger vitamin need per calorie of food intake.[135]

Increased need

[edit]

Increased needs by the body can occur due to AIDS and hemolysis (the breakdown of red blood cells), which stimulates increased red cell production.[1]

Mechanism

[edit]
MRI image of the brain in vitamin B12 deficiency, axial view showing the "precontrast FLAIR image": note the abnormal lesions (circled) in the periventricular area suggesting white matter pathology.

Physiology

[edit]

The total amount of vitamin B12 stored in the body is between two and five milligrams in adults. Approximately 50% is stored in the liver, but approximately 0.1% is lost each day, due to secretions into the gut – not all of the vitamin in the gut is reabsorbed. While bile is the main vehicle for B12 excretion, most of this is recycled via enterohepatic circulation. Due to the extreme efficiency of this mechanism, the liver can store three to five years worth of vitamin B12 under normal conditions and functioning.[136] However, the rate at which B12 levels may change when dietary intake is low depends on the balance between several variables.[137]

The human physiology of active vitamin B12 absorption from food is complex. When foods containing B12 are eaten, the vitamin is usually bound to protein and is released by proteases released by the pancreas in the small intestine. Following its release, most B12 is absorbed in the ileum, the last part of the small intestine, after binding to a protein known as intrinsic factor.

Pathophysiology

[edit]
Further information: Vitamin B12 § Coenzyme function

Vitamin B12 deficiency causes particular changes to the metabolism of two clinically relevant substances in humans:

  1. Homocysteine (homocysteine to methionine, catalysed by methionine synthase) leading to hyperhomocysteinemia
  2. Methylmalonic acid (methylmalonyl-CoA to succinyl-CoA, of which methylmalonyl-CoA is made from methylmalonic acid in a preceding reaction)

Methionine is activated to S-adenosyl methionine, which aids in purine and thymidine synthesis, myelin production, protein/neurotransmitters/fatty acid/phospholipid production and DNA methylation. 5-methyl tetrahydrofolate provides a methyl group, which is released to the reaction with homocysteine, resulting in methionine. This reaction requires cobalamin as a cofactor. The creation of 5-methyl tetrahydrofolate is an irreversible reaction. If B12 is absent, the forward reaction of homocysteine to methionine does not occur, homocysteine concentrations increase, and the replenishment of tetrahydrofolate stops.[138] Because B12 and folate are involved in the metabolism of homocysteine, hyperhomocysteinuria is a non-specific marker of deficiency. Methylmalonic acid is used as a test of B12 deficiency, but has a low specificity.

Nervous system

[edit]

Early changes include a spongiform state of neural tissue, along with edema of fibers and deficiency of tissue. The myelin decays, along with axial fiber. In later phases, fibric sclerosis of nervous tissues occurs. Those changes occur in dorsal parts of the spinal cord and to pyramidal tracts in lateral cords and are called subacute combined degeneration of spinal cord.[139] Pathological changes can be noticed as well in the posterior roots of the cord and, to lesser extent, in peripheral nerves.

In the brain itself, changes are less severe: They occur as small sources of nervous fibers decay and accumulation of astrocytes, usually subcortically located, and also round hemorrhages with a torus of glial cells.

MRI of the brain may show periventricular white matter abnormalities. MRI of the spinal cord may show linear hyperintensity in the posterior portion of the cervical tract of the spinal cord, with selective involvement of the posterior columns.

Diagnosis

[edit]
Schematic representation of the propionate metabolic pathway. Methylmalonyl-CoA mutase requires the coenzyme adenosylcobalamin in order to convert L-methylmalonyl-CoA into succinyl-CoA. Otherwise, methylmalonic acid accumulates, which can be a marker for vitamin B12 deficiency, among other things.

A diagnosis of vitamin B12 deficiency is determined by blood levels lower than 200 or 250 picograms per ml (148 or 185 picomoles per liter). Measurement of blood methylmalonic acid (MMA), a vitamin B12-associated metabolite, is a commonly used biomarker.[2] Deficiency is often suspected first, as diagnosis usually requires several tests.[2][140] There is no gold standard assay to confirm a vitamin B12 deficiency.[141]

Blood tests may show low levels of vitamin B12, elevated levels of methylmalonic acid or homocysteine, and a routine complete blood counts may shows anemia with an elevated mean cell volume.[140] The presence of antibodies to gastric parietal cells and intrinsic factor may indicate pernicious anemia.[2]

Deficiency can develop without anemia or within normal vitamin B12 levels, leading to a methylmalonic acid or homocysteine assay.[2][4][142][143] In some cases, a peripheral blood smear may be used; which may allow to show macrocytes and hypersegmented polymorphonuclear leukocytes.[140] Neuropsychiatric symptoms can precede hematological signs and are often the presenting manifestation of B12 deficiency.[144] Anemia can be prevented or masked by folic acid in which activate tetrahydrofolate (THF) needed for DNA synthesis.[145]

However, elevated methylmalonic acid levels may also be related to metabolic disorders such as methylmalonic acidemia. If elevated methylmalonic acid levels are further accompanied by elevated malonic acid levels, this may be indicative of combined malonic and methylmalonic aciduria (CMAMMA).[146]

If nervous system damage is present and blood testing is inconclusive, a lumbar puncture to measure cerebrospinal fluid B-12 levels may be done.[147] On bone marrow aspiration or biopsy, megaloblasts are seen.[148]

The Schilling test was a radio-isotope method, now outdated, of testing for low vitamin B12.[140][149]

Serum levels

[edit]
Further information: Reference ranges for blood tests § Vitamins

A blood test shows vitamin B12 levels in the blood. Vitamin B12 deficiency can be determined, but not always.[14] This means it measures forms of vitamin B12 that are "active" and can be used by the body, as well as the "inactive" forms, which cannot.[150] Vitamin B12 deficiency can be found within normal levels, so clinical symptoms should be taken into account when a diagnosis is made.[2] Normal blood levels are considered to be at least above 300 pg/mL in adults.[2] Some researchers have suggested that current standards for vitamin B12 levels are too low.[151]

Treatment

[edit]
Hydroxocobalamin injection is a clear red liquid solution.

Treatment should take into account the cause and severity of the condition.[6] Treatment is done by vitamin B12 supplementation, either by mouth or by injection.[3] Initially in high daily doses, followed by less frequent lower doses, as the condition improves.[3] If a reversible cause is found, that cause should be corrected if possible.[11] If no reversible cause is found, or when found it cannot be eliminated, lifelong vitamin B12 administration is usually recommended.[12] More serious vitamin B12 deficiency requires injections initially.[3] A 2019 study suggested that oral B12 is inferior to B12 injections in severe cases, as "there is no proof in large prospective, double-blind studies that oral supplementation is as effective in reducing symptoms associated with vitamin B12 deficiency as parenteral treatment."[152]

There is risk that folic acid administered to those with untreated B12 deficiency may mask anemia without solving the issue at hand in which, if left untreated, can cause lasting serious side effects that affect the nervous system and brain.[153]

Measuring vitamin B12 values during or after treatment, in order to measure the effectiveness of treatment, is useless.[154]

Epidemiology

[edit]

Vitamin B12 deficiency is common and occurs worldwide. In the US and UK, around 6 percent of the general population have the deficiency; in those over the age of sixty, around 20 percent are deficient. In under-developed countries, the rates are even higher: across Latin America 40 percent are deficient; in some parts of Africa, 70 percent; and in some parts of India, 70 to 80 percent.[1]

According to the World Health Organization (WHO), vitamin B12 deficiency may be considered a global public health problem affecting millions of individuals.[155] However, the incidence and prevalence of vitamin B12 deficiency worldwide is unknown due to the limited population-based data available (see table below).

Developed countries such as the United States, Germany and the United Kingdom have relatively constant mean vitamin B12 concentrations.[156] The data from the National Health and Nutrition Examination Survey (NHANES) reported the prevalence of serum vitamin B12 concentrations in the United States population between 1999 and 2002.[157][158] Serum vitamin B12 concentrations of < 148 pmol/L was present in < 1% of children and adolescents. In adults aged 20–39 years, concentrations were below this cut-off in ≤ 3% of individuals. In the elderly (70 years and older), ≈ 6% of persons had a vitamin B12 concentration below the cut-off.

Furthermore, ≈ 14–16% of adults and > 20% of elderly individuals showed evidence of marginal vitamin B12 depletion (serum vitamin B12: 148–221 pmol/L).[157][158] In the United Kingdom, a National Diet and Nutrition Survey (NDNS) was conducted in adults aged between 19 and 64 years in 2000–2001[159] and in elderly individuals (≥ 65 years) in 1994–95.[160] Six percent of men (n = 632) and 10% of women (n = 667) had low serum vitamin B12 concentrations, defined as < 150 pmol/L. In a subgroup of women of reproductive age (19 to 49 years), 11% had low serum B12 concentrations < 150 pmol/L (n = 476). The prevalence of vitamin B12 deficiency increased substantially in the elderly, where 31% of the elderly had vitamin B12 levels below 130 pmol/L. In the most recent NDNS survey conducted between 2008 and 2011, serum vitamin B12 was measured in 549 adults.[161] The mean serum vitamin B12 concentration for men (19–64 years) was 308 pmol/L, of which 0.9% of men had low serum B12 concentrations < 150 pmol/L. In women aged between 19 and 64 years, the mean serum vitamin B12 concentration was slightly lower than men (298 pmol/L), with 3.3% having low vitamin B12 concentrations < 150 pmol/L.[161] In Germany, a national survey in 1998 was conducted in 1,266 women of childbearing age. Approximately, 14.7% of these women had mean serum vitamin B12 concentrations of < 148 pmol/L.[162]

Few studies have reported vitamin B12 status on a national level in non-Western countries.[163] Of these reported studies, vitamin B12 deficiency was prevalent among school-aged children in Venezuela (11.4%),[164] children aged 1–6 years in Mexico (7.7%),[165] women of reproductive age in Vietnam (11.7%),[166] pregnant women in Venezuela (61.34%)[164] and in the elderly population (> 65 years) in New Zealand (12%).[167] Currently, there are no nationally representative surveys for any African or South Asian countries. However, the very few surveys which have investigated vitamin B12 deficiency in these countries have been based on local or district level data. These surveys have reported a high prevalence of vitamin B12 deficiency (< 150 pmol/L), among 36% of breastfed and 9% of non-breastfed children (n = 2482) in New Delhi[168] and 47% of adults (n = 204)[169] in Pune, Maharashtra, India. Furthermore, in Kenya a local district survey in Embu (n = 512) revealed that 40% of school-aged children in Kenya had vitamin B12 deficiency.[170]

Worldwide prevalence of vitamin B12 deficiency (serum/plasma B12 < 148 or 150 pmol/L)
Group Number of studies Number of
participants 		Vitamin B12 deficiency (%)
Children (< 1y – 18 years) 14 22,331 12.5
Pregnant women 11 11,381 27.5
Non-pregnant women 16 18,520 16
All adults (under 60 years) 18 81.438 6
Elderly (60+ years) 25 30,449 19

Derived from Table 2 available on [171]

History

[edit]

Between 1849 and 1887, Thomas Addison described a case of pernicious anemia, William Osler and William Gardner first described a case of neuropathy, Hayem described large red cells in the peripheral blood in this condition, which he called "giant blood corpuscles" (now called macrocytes), Paul Ehrlich identified megaloblasts in the bone marrow, and Ludwig Lichtheim described a case of myelopathy.[172] During the 1920s, George Whipple discovered that ingesting large amounts of liver seemed to most rapidly cure the anemia of blood loss in dogs, and hypothesized that eating liver might treat pernicious anemia.[173] Edwin Cohn prepared a liver extract that was 50 to 100 times more potent in treating pernicious anemia than the natural liver products. William Castle demonstrated that gastric juice contained an "intrinsic factor" which when combined with meat ingestion resulted in absorption of the vitamin in this condition.[172] In 1934, George Whipple shared the 1934 Nobel Prize in Physiology or Medicine with William P. Murphy and George Minot for discovery of an effective treatment for pernicious anemia using liver concentrate, later found to contain a large amount of vitamin B12.[172][174]

Other animals

[edit]

Ruminants, such as cattle and sheep, absorb B12 synthesized by their gut bacteria. Sufficient amounts of cobalt and copper need to be consumed for this B12 synthesis to occur.[175]

In the early 20th century, during the development for farming of the North Island Volcanic Plateau of New Zealand, cattle had what was termed "bush sickness". It was discovered in 1934 that the volcanic soils lacked the cobalt salts essential for synthesis of vitamin B12 by their gut bacteria.[176][175] The "coast disease" of sheep in the coastal sand dunes of South Australia in the 1930s was found to originate in nutritional deficiencies of the trace elements, cobalt and copper. The cobalt deficiency was overcome by the development of "cobalt bullets", dense pellets of cobalt oxide mixed with clay given orally, which then was retained in the animal's rumen.[175][177]

References

[edit]
  1. ^ a b c d e f g h i j k l m n o p q Hunt A, Harrington D, Robinson S (September 2014). "Vitamin B12 deficiency" (PDF). BMJ. 349: g5226. doi:10.1136/bmj.g5226. PMID 25189324. S2CID 28782021. Archived from the original (PDF) on March 12, 2017.
  2. ^ a b c d e f g h i j k l m n o p q r s t u v w x "Vitamin B12 – Fact Sheet for Health Professionals". National Institutes of Health, Office of Dietary Supplements. December 22, 2022. Retrieved February 28, 2023.
  3. ^ a b c d e f Wang H, Li L, Qin LL, Song Y, Vidal-Alaball J, Liu TH (March 2018). "Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency". The Cochrane Database of Systematic Reviews. 2018 (3): CD004655. doi:10.1002/14651858.CD004655.pub3. PMC 5112015. PMID 29543316.
  4. ^ a b c Langan RC, Goodbred AJ (September 2017). "Vitamin B12 Deficiency: Recognition and Management". American Family Physician. 96 (6): 384–389. PMID 28925645.
  5. ^ a b Herrmann W (2011). Vitamins in the prevention of human diseases. Berlin: Walter de Gruyter. p. 245. ISBN 978-3-11-021448-2.
  6. ^ a b c "Pernicious Anemia Clinical Presentation: History, Physical Examination". September 14, 2017. Archived from the original on September 14, 2017. Retrieved November 28, 2021.
  7. ^ a b c "Vitamin B12 or folate deficiency anaemia – Complications". NHS UK. November 18, 2021.
  8. ^ a b c d e Azzini E, Raguzzini A, Polito A (September 2021). "A Brief Review on Vitamin B12 Deficiency Looking at Some Case Study Reports in Adults". International Journal of Molecular Sciences. 22 (18): 9694. doi:10.3390/ijms22189694. PMC 8471716. PMID 34575856.
  9. ^ Miller JW (July 2018). "Proton Pump Inhibitors, H2-Receptor Antagonists, Metformin, and Vitamin B-12 Deficiency: Clinical Implications". Advances in Nutrition. 9 (4): 511S–518S. doi:10.1093/advances/nmy023. PMC 6054240. PMID 30032223.
  10. ^ Hamilton MS, Blackmore S, Lee A (May 14, 2022). "Further cases of false normal B12 assays – intrinsic factor antibody interference a possible mechanism?". BMJ.
  11. ^ a b Hankey GJ, Wardlaw JM (2008). Clinical neurology. London: Manson. p. 466. ISBN 978-1-84076-518-2.
  12. ^ a b Schwartz W (2012). The 5-minute pediatric consult (6th ed.). Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. p. 535. ISBN 978-1-4511-1656-4.
  13. ^ Kim J, Kim MJ, Kho HS (May 2016). "Oral manifestations in vitamin B12 deficiency patients with or without history of gastrectomy". BMC Oral Health. 16 (1): 60. doi:10.1186/s12903-016-0215-y. PMC 4884371. PMID 27234214.
  14. ^ a b Scarpa E, Candiotto L, Sartori R, Radossi P, Maschio N, Tagariello G (October 2013). "Undetected vitamin B12 deficiency due to false normal assay results". Blood Transfusion = Trasfusione del Sangue. 11 (4): 627–629. doi:10.2450/2012.0183-12. PMC 3827408. PMID 23356970.
  15. ^ "Vitamin B12 Deficiency – Disorders of Nutrition". MSD Manual Consumer Version. Retrieved October 15, 2021.
  16. ^ a b "Vitamin B12 Deficiency: Causes, Symptoms, and Treatment". July 28, 2021. Archived from the original on July 28, 2021. Retrieved September 13, 2021.
  17. ^ Reynolds EH (2014). "The neurology of folic acid deficiency". In Biller J, Ferro JM (eds.). Neurologic aspects of systemic disease. Handbook of Clinical Neurology. Vol. 120. pp. 927–943. doi:10.1016/B978-0-7020-4087-0.00061-9. ISBN 978-0-7020-4087-0. PMID 24365361.
  18. ^ "Vitamin B12 Deficiency Anemia | Michigan Medicine". www.uofmhealth.org. Retrieved October 8, 2021.
  19. ^ "How a Vitamin B Deficiency Affects Blood Pressure". Livestrong.comlanguage=en. Retrieved September 13, 2021.
  20. ^ "Vitamin B12 or folate deficiency anaemia". HSE.ie. Retrieved December 5, 2021.
  21. ^ "Articles". Cedars-Sinai. Archived from the original on May 30, 2020. Retrieved September 13, 2021.
  22. ^ Harvard Health Publishing Staff (January 10, 2013). "Vitamin B12 deficiency can be sneaky, harmful". Harvard Health. Retrieved March 11, 2022.
  23. ^ Li K, McKay G (March 2000). "Images in clinical medicine. Ischemic retinopathy caused by severe megaloblastic anemia". The New England Journal of Medicine. 342 (12): 860. doi:10.1056/NEJM200003233421205. PMID 10727590.
  24. ^ Qudsiya Z, De Jesus O (2022). "Subacute Combined Degeneration of the Spinal Cord". StatPearls. StatPearls Publishing. PMID 32644742. Retrieved February 19, 2022.
  25. ^ a b Tsoriev A. "Subacute combined degeneration of the cord (funicular myelosis) | Radiology Case | Radiopaedia.org". Radiopaedia. Retrieved February 5, 2022.
  26. ^ Dudorova EY, Damulin IV, Khatkov IE (2015). "[Neurological complications due to vitamin deficiencies after bariatric surgery]". Terapevticheskii Arkhiv. 87 (12): 117–121. doi:10.17116/terarkh20158712117-121. PMID 27035000.
  27. ^ Hasbaoui BE, Mebrouk N, Saghir S, Yajouri AE, Abilkassem R, Agadr A (2021). "Vitamin B12 deficiency: case report and review of literature". The Pan African Medical Journal. 38: 237. doi:10.11604/pamj.2021.38.237.20967 (inactive November 1, 2024). PMC 8140678. PMID 34046142.{{cite journal}}: CS1 maint: DOI inactive as of November 2024 (link)
  28. ^ Moore E, Mander A, Ames D, Carne R, Sanders K, Watters D (April 2012). "Cognitive impairment and vitamin B12: a review". International Psychogeriatrics. 24 (4): 541–556. doi:10.1017/S1041610211002511. PMID 22221769. S2CID 206300763.
  29. ^ Zempleni J, Suttie JW, Gregory III JF, Stover PJ, eds. (2014). Handbook of vitamins (Fifth ed.). Hoboken: CRC Press. p. 477. ISBN 978-1-4665-1557-4. Archived from the original on August 17, 2016.
  30. ^ O'Gorman P, Holmes D, Ramanan AV, Bose-Haider B, Lewis MJ, Will A (June 2002). "Dietary vitamin B12 deficiency in an adolescent white boy". Journal of Clinical Pathology. 55 (6): 475–476. doi:10.1136/jcp.55.6.475. PMC 1769668. PMID 12037034.
  31. ^ Briani C, Dalla Torre C, Citton V, Manara R, Pompanin S, Binotto G, et al. (November 2013). "Cobalamin deficiency: clinical picture and radiological findings". Nutrients. 5 (11): 4521–4539. doi:10.3390/nu5114521. PMC 3847746. PMID 24248213.
  32. ^ "Watermelon stomach | Genetic and Rare Diseases Information Center (GARD) – an NCATS Program". rarediseases.info.nih.gov. Retrieved February 18, 2022.
  33. ^ Amarapurka DN, Patel ND (September 2004). "Gastric Antral Vascular Ectasia (GAVE) Syndrome" (PDF). Journal of the Association of Physicians of India. 52: 757. Archived (PDF) from the original on March 4, 2016.
  34. ^ Matsumoto A, Shiga Y, Shimizu H, Kimura I, Hisanaga K (April 2009). "[Encephalomyelopathy due to vitamin B12 deficiency with seizures as a predominant symptom]". Rinsho Shinkeigaku = Clinical Neurology. 49 (4): 179–185. doi:10.5692/clinicalneurol.49.179. PMID 19462816.
  35. ^ Kumar S (March 2004). "Recurrent seizures: an unusual manifestation of vitamin B12 deficiency". Neurology India. 52 (1): 122–123. PMID 15069260. Archived from the original on January 23, 2011.
  36. ^ Kliegman RM, Stanton BF, St Geme J (2016). Kliegman RM, Stanton B, St Geme J, Schor NF (eds.). Nelson Textbook of Pediatrics (20th ed.). Elsevier Health Sciences. pp. 2319–2326. ISBN 978-1-4557-7566-8.
  37. ^ a b Black MM (June 2008). "Effects of vitamin B12 and folate deficiency on brain development in children". Food and Nutrition Bulletin. 29 (2 Suppl): S126–S131. doi:10.1177/15648265080292S117. PMC 3137939. PMID 18709887.
  38. ^ a b c d Knight BA, Shields BM, Brook A, Hill A, Bhat DS, Hattersley AT, et al. (August 19, 2015). Sengupta S (ed.). "Lower Circulating B12 Is Associated with Higher Obesity and Insulin Resistance during Pregnancy in a Non-Diabetic White British Population". PLOS ONE. 10 (8): e0135268. Bibcode:2015PLoSO..1035268K. doi:10.1371/journal.pone.0135268. PMC 4545890. PMID 26288227.
  39. ^ a b c "Erratum for Sukumar N et al. Prevalence of vitamin B-12 insufficiency during pregnancy and its effect on offspring birth weight: a systematic review and meta-analysis. Am J Clin Nutr 2016; 103:1232–1251". The American Journal of Clinical Nutrition. 105 (1): 241.1–241. January 2017. doi:10.3945/ajcn.116.148585. PMID 28049667.
  40. ^ a b c Yajnik CS, Deshpande SS, Jackson AA, Refsum H, Rao S, Fisher DJ, et al. (January 2008). "Vitamin B12 and folate concentrations during pregnancy and insulin resistance in the offspring: the Pune Maternal Nutrition Study". Diabetologia. 51 (1): 29–38. doi:10.1007/s00125-007-0793-y. PMC 2100429. PMID 17851649.
  41. ^ Krishnaveni GV, Hill JC, Veena SR, Bhat DS, Wills AK, Karat CL, et al. (November 2009). "Low plasma vitamin B12 in pregnancy is associated with gestational 'diabesity' and later diabetes". Diabetologia. 52 (11): 2350–2358. doi:10.1007/s00125-009-1499-0. PMC 3541499. PMID 19707742.
  42. ^ Sinclair KD, Allegrucci C, Singh R, Gardner DS, Sebastian S, Bispham J, et al. (December 2007). "DNA methylation, insulin resistance, and blood pressure in offspring determined by maternal periconceptional B vitamin and methionine status". Proceedings of the National Academy of Sciences of the United States of America. 104 (49): 19351–19356. Bibcode:2007PNAS..10419351S. doi:10.1073/pnas.0707258104. PMC 2148293. PMID 18042717.
  43. ^ Finer S, Saravanan P, Hitman G, Yajnik C (March 2014). "The role of the one-carbon cycle in the developmental origins of Type 2 diabetes and obesity". Diabetic Medicine. 31 (3): 263–272. doi:10.1111/dme.12390. PMID 24344881. S2CID 36014480.
  44. ^ Krikke GG, Grooten IJ, Vrijkotte TG, van Eijsden M, Roseboom TJ, Painter RC (February 2016). "Vitamin B12 and folate status in early pregnancy and cardiometabolic risk factors in the offspring at age 5–6 years: findings from the ABCD multi-ethnic birth cohort". BJOG. 123 (3): 384–392. doi:10.1111/1471-0528.13574. PMID 26810674. S2CID 1822164.
  45. ^ a b Adaikalakoteswari A, Vatish M, Alam MT, Ott S, Kumar S, Saravanan P (November 2017). "Low Vitamin B12 in Pregnancy Is Associated With Adipose-Derived Circulating miRs Targeting PPARγ and Insulin Resistance". The Journal of Clinical Endocrinology and Metabolism. 102 (11): 4200–4209. doi:10.1210/jc.2017-01155. PMID 28938471.
  46. ^ Chango A, Pogribny IP (April 2015). "Considering maternal dietary modulators for epigenetic regulation and programming of the fetal epigenome". Nutrients. 7 (4): 2748–2770. doi:10.3390/nu7042748. PMC 4425171. PMID 25875118.
  47. ^ Yajnik CS, Deshmukh US (June 2012). "Fetal programming: maternal nutrition and role of one-carbon metabolism". Reviews in Endocrine & Metabolic Disorders. 13 (2): 121–127. doi:10.1007/s11154-012-9214-8. PMID 22415298. S2CID 11186195.
  48. ^ a b Rogne T, Tielemans MJ, Chong MF, Yajnik CS, Krishnaveni GV, Poston L, et al. (February 2017). "Associations of Maternal Vitamin B12 Concentration in Pregnancy With the Risks of Preterm Birth and Low Birth Weight: A Systematic Review and Meta-Analysis of Individual Participant Data". American Journal of Epidemiology. 185 (3): 212–223. doi:10.1093/aje/kww212. PMC 5390862. PMID 28108470.
  49. ^ Molloy AM, Kirke PN, Troendle JF, Burke H, Sutton M, Brody LC, et al. (March 2009). "Maternal vitamin B12 status and risk of neural tube defects in a population with high neural tube defect prevalence and no folic Acid fortification". Pediatrics. 123 (3): 917–923. doi:10.1542/peds.2008-1173. hdl:2262/34511. PMC 4161975. PMID 19255021.
  50. ^ Ray JG, Wyatt PR, Thompson MD, Vermeulen MJ, Meier C, Wong PY, et al. (May 2007). "Vitamin B12 and the risk of neural tube defects in a folic-acid-fortified population". Epidemiology. 18 (3): 362–366. doi:10.1097/01.ede.0000257063.77411.e9. PMID 17474166. S2CID 21094981.
  51. ^ "Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects". QJM: An International Journal of Medicine. 86 (11): 703–708. November 1993. doi:10.1093/oxfordjournals.qjmed.a068749. ISSN 1460-2393.
  52. ^ Gaber, K.R., et al., Maternal vitamin B12 and the risk of fetal neural tube defects in Egyptian patients. Clin Lab, 2007. 53(1–2): pp. 69–75.
  53. ^ Lövblad K, Ramelli G, Remonda L, Nirkko AC, Ozdoba C, Schroth G (February 1997). "Retardation of myelination due to dietary vitamin B12 deficiency: cranial MRI findings" (PDF). Pediatric Radiology. 27 (2): 155–158. doi:10.1007/s002470050090. PMID 9028851. S2CID 25039442.
  54. ^ Li Z, Gueant-Rodriguez RM, Quilliot D, Sirveaux MA, Meyre D, Gueant JL, et al. (October 2018). "Folate and vitamin B12 status is associated with insulin resistance and metabolic syndrome in morbid obesity". Clinical Nutrition. 37 (5): 1700–1706. doi:10.1016/j.clnu.2017.07.008. PMID 28780990. S2CID 28557054.
  55. ^ a b c Pinhas-Hamiel O, Doron-Panush N, Reichman B, Nitzan-Kaluski D, Shalitin S, Geva-Lerner L (September 2006). "Obese children and adolescents: a risk group for low vitamin B12 concentration". Archives of Pediatrics & Adolescent Medicine. 160 (9): 933–936. doi:10.1001/archpedi.160.9.933. PMID 16953016.
  56. ^ MacFarlane AJ, Greene-Finestone LS, Shi Y (October 2011). "Vitamin B-12 and homocysteine status in a folate-replete population: results from the Canadian Health Measures Survey". The American Journal of Clinical Nutrition. 94 (4): 1079–1087. doi:10.3945/ajcn.111.020230. PMID 21900461.
  57. ^ Madan AK, Orth WS, Tichansky DS, Ternovits CA (May 2006). "Vitamin and trace mineral levels after laparoscopic gastric bypass". Obesity Surgery. 16 (5): 603–606. doi:10.1381/096089206776945057. PMID 16687029. S2CID 31410788.
  58. ^ a b Nachtigal MC, Patterson RE, Stratton KL, Adams LA, Shattuck AL, White E (October 2005). "Dietary supplements and weight control in a middle-age population". Journal of Alternative and Complementary Medicine. 11 (5): 909–915. doi:10.1089/acm.2005.11.909. PMID 16296926.
  59. ^ Dick KJ, Nelson CP, Tsaprouni L, Sandling JK, Aïssi D, Wahl S, et al. (June 2014). "DNA methylation and body-mass index: a genome-wide analysis". Lancet. 383 (9933): 1990–1998. doi:10.1016/S0140-6736(13)62674-4. PMID 24630777. S2CID 18026508.
  60. ^ Adaikalakoteswari A, Jayashri R, Sukumar N, Venkataraman H, Pradeepa R, Gokulakrishnan K, et al. (September 2014). "Vitamin B12 deficiency is associated with adverse lipid profile in Europeans and Indians with type 2 diabetes". Cardiovascular Diabetology. 13 (1): 129. doi:10.1186/s12933-014-0129-4. PMC 4189588. PMID 25283155.
  61. ^ Wall, С., Food and Nutrition Guidelines for Healthy Adolescents. Ministry of Health. Wellington, New Zealand, 1998.
  62. ^ a b Thomas-Valdés S, Tostes MD, Anunciação PC, da Silva BP, Sant'Ana HM (October 2017). "Association between vitamin deficiency and metabolic disorders related to obesity". Critical Reviews in Food Science and Nutrition. 57 (15): 3332–3343. doi:10.1080/10408398.2015.1117413. PMID 26745150. S2CID 19077356.
  63. ^ Debreceni B, Debreceni L (June 2014). "The role of homocysteine-lowering B-vitamins in the primary prevention of cardiovascular disease". Cardiovascular Therapeutics. 32 (3): 130–138. doi:10.1111/1755-5922.12064. PMID 24571382.
  64. ^ Selhub J (July 1999). "Homocysteine metabolism". Annual Review of Nutrition. 19 (1): 217–246. doi:10.1146/annurev.nutr.19.1.217. PMID 10448523.
  65. ^ Wald DS, Law M, Morris JK (November 2002). "Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis". BMJ. 325 (7374): 1202–1206. doi:10.1136/bmj.325.7374.1202. PMC 135491. PMID 12446535.
  66. ^ Setola E, Monti LD, Galluccio E, Palloshi A, Fragasso G, Paroni R, et al. (October 2004). "Insulin resistance and endothelial function are improved after folate and vitamin B12 therapy in patients with metabolic syndrome: relationship between homocysteine levels and hyperinsulinemia". European Journal of Endocrinology. 151 (4): 483–489. doi:10.1530/eje.0.1510483. PMID 15476449.
  67. ^ Guven A, Inanc F, Kilinc M, Ekerbicer H (November 2005). "Plasma homocysteine and lipoprotein (a) levels in Turkish patients with metabolic syndrome". Heart and Vessels. 20 (6): 290–295. doi:10.1007/s00380-004-0822-4. PMID 16314912. S2CID 19304098.
  68. ^ Danesh J, Lewington S, Thompson SG, Lowe GD, Collins R, Kostis JB, et al. (October 2005). "Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis" (PDF). JAMA. 294 (14): 1799–1809. doi:10.1001/jama.294.14.1799. PMID 16219884. S2CID 6128916.
  69. ^ Welsh P, Lowe GD, Chalmers J, Campbell DJ, Rumley A, Neal BC, et al. (August 2008). "Associations of proinflammatory cytokines with the risk of recurrent stroke". Stroke. 39 (8): 2226–2230. doi:10.1161/STROKEAHA.107.504498. PMID 18566306.
  70. ^ a b c Wiebe N, Field CJ, Tonelli M (November 2018). "A systematic review of the vitamin B12, folate and homocysteine triad across body mass index". Obesity Reviews. 19 (11): 1608–1618. doi:10.1111/obr.12724. PMID 30074676. S2CID 51908596.
  71. ^ Mahabir S, Ettinger S, Johnson L, Baer DJ, Clevidence BA, Hartman TJ, et al. (May 2008). "Measures of adiposity and body fat distribution in relation to serum folate levels in postmenopausal women in a feeding study". European Journal of Clinical Nutrition. 62 (5): 644–650. doi:10.1038/sj.ejcn.1602771. PMC 3236439. PMID 17457338.
  72. ^ Reitman A, Friedrich I, Ben-Amotz A, Levy Y (August 2002). "Low plasma antioxidants and normal plasma B vitamins and homocysteine in patients with severe obesity". The Israel Medical Association Journal. 4 (8): 590–593. PMID 12183861.
  73. ^ Zhu W, Huang X, Li M, Neubauer H (May 2006). "Elevated plasma homocysteine in obese schoolchildren with early atherosclerosis". European Journal of Pediatrics. 165 (5): 326–331. doi:10.1007/s00431-005-0033-8. PMID 16344991. S2CID 24549104.
  74. ^ Aasheim ET, Hofsø D, Hjelmesaeth J, Birkeland KI, Bøhmer T (February 2008). "Vitamin status in morbidly obese patients: a cross-sectional study". The American Journal of Clinical Nutrition. 87 (2): 362–369. doi:10.1093/ajcn/87.2.362. PMID 18258626.
  75. ^ Damião CP, Rodrigues AO, Pinheiro MF, Cruz RA, Cardoso GP, Taboada GF, et al. (June 3, 2016). "Prevalence of vitamin B12 deficiency in type 2 diabetic patients using metformin: a cross-sectional study". Sao Paulo Medical Journal = Revista Paulista de Medicina. 134 (6): 473–479. doi:10.1590/1516-3180.2015.01382111. PMC 11448733. PMID 28076635.
  76. ^ Akabwai GP, Kibirige D, Mugenyi L, Kaddu M, Opio C, Lalitha R, et al. (December 2015). "Vitamin B12 deficiency among adult diabetic patients in Uganda: relation to glycaemic control and haemoglobin concentration". Journal of Diabetes and Metabolic Disorders. 15 (1): 26. doi:10.1186/s40200-016-0250-x. PMC 4962419. PMID 27468410.
  77. ^ Kaya C, Cengiz SD, Satiroğlu H (November 2009). "Obesity and insulin resistance associated with lower plasma vitamin B12 in PCOS". Reproductive Biomedicine Online. 19 (5): 721–726. doi:10.1016/j.rbmo.2009.06.005. PMID 20021721.
  78. ^ Iglesia I, González-Gross M, Huybrechts I, De Miguel-Etayo P, Molnar D, Manios Y, et al. (June 2017). "[Associations between insulin resistance and three B-vitamins in European adolescents: the HELENA study]". Nutricion Hospitalaria. 34 (3): 568–577. doi:10.20960/nh.559 (inactive November 1, 2024). hdl:1854/LU-8731273. PMID 28627191.{{cite journal}}: CS1 maint: DOI inactive as of November 2024 (link)
  79. ^ Jayashri R, Venkatesan U, Rohan M, Gokulakrishnan K, Shanthi Rani CS, Deepa M, et al. (December 2018). "Prevalence of vitamin B12 deficiency in South Indians with different grades of glucose tolerance". Acta Diabetologica. 55 (12): 1283–1293. doi:10.1007/s00592-018-1240-x. PMID 30317438. S2CID 52977621.
  80. ^ Vayá A, Rivera L, Hernández-Mijares A, de la Fuente M, Solá E, Romagnoli M, et al. (2012). "Homocysteine levels in morbidly obese patients: its association with waist circumference and insulin resistance". Clinical Hemorheology and Microcirculation. 52 (1): 49–56. doi:10.3233/CH-2012-1544. PMID 22460264.
  81. ^ Reinstatler L, Qi YP, Williamson RS, Garn JV, Oakley GP (February 2012). "Association of biochemical B₁₂ deficiency with metformin therapy and vitamin B₁₂ supplements: the National Health and Nutrition Examination Survey, 1999–2006". Diabetes Care. 35 (2): 327–333. doi:10.2337/dc11-1582. PMC 3263877. PMID 22179958.
  82. ^ Hampel H, Abraham NS, El-Serag HB (August 2005). "Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications". Annals of Internal Medicine. 143 (3): 199–211. doi:10.7326/0003-4819-143-3-200508020-00006. PMID 16061918. S2CID 15540274.
  83. ^ a b Rafnsson SB, Saravanan P, Bhopal RS, Yajnik CS (March 2011). "Is a low blood level of vitamin B12 a cardiovascular and diabetes risk factor? A systematic review of cohort studies". European Journal of Nutrition. 50 (2): 97–106. doi:10.1007/s00394-010-0119-6. PMID 20585951. S2CID 28405065.
  84. ^ a b Jayedi A, Zargar MS (September 8, 2019). "Intake of vitamin B6, folate, and vitamin B12 and risk of coronary heart disease: a systematic review and dose-response meta-analysis of prospective cohort studies". Critical Reviews in Food Science and Nutrition. 59 (16): 2697–2707. doi:10.1080/10408398.2018.1511967. PMID 30431328. S2CID 53430399.
  85. ^ Metz J (June 2008). "A high prevalence of biochemical evidence of vitamin B12 or folate deficiency does not translate into a comparable prevalence of anemia". Food and Nutrition Bulletin. 29 (2 Suppl): S74–S85. doi:10.1177/15648265080292S111. PMID 18709883. S2CID 24852101.
  86. ^ Edelstein T, Stevens K, Baumslag N, Metz J (February 1968). "Folic acid and vitamin B12 supplementation during pregnancy in a population subsisting on a suboptimal diet". The Journal of Obstetrics and Gynaecology of the British Commonwealth. 75 (2): 133–137. doi:10.1111/j.1471-0528.1968.tb02022.x. PMID 5641006. S2CID 45266873.
  87. ^ Shahab-Ferdows, S., Randomized Placebo-controlled Vitamin B12 Supplementation Trial in Deficient Rural Mexican Women: Baseline Assessment, Transcobalamin Genotype and Response of Biochemical and Functional Markers to Supplementation. 2007: University of California, Davis.
  88. ^ Reid, E.D., et al., Hematological and biochemical responses of rural Mexican preschoolers to iron alone or iron plus micronutrients. Vol. 15. 2001. A731.
  89. ^ a b c O'Leary F, Samman S (March 2010). "Vitamin B12 in health and disease". Nutrients. 2 (3): 299–316. doi:10.3390/nu2030299. PMC 3257642. PMID 22254022.
  90. ^ Foran S, Wang JJ, Mitchell P (October 2003). "Causes of visual impairment in two older population cross-sections: the Blue Mountains Eye Study". Ophthalmic Epidemiology. 10 (4): 215–225. doi:10.1076/opep.10.4.215.15906. PMID 14628964. S2CID 29358674.
  91. ^ Pennington KL, DeAngelis MM (December 2016). "Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors". Eye and Vision. 3 (1): 34. doi:10.1186/s40662-016-0063-5. PMC 5178091. PMID 28032115.
  92. ^ Al-Zamil WM, Yassin SA (August 2017). "Recent developments in age-related macular degeneration: a review". Clinical Interventions in Aging. 12: 1313–1330. doi:10.2147/CIA.S143508. PMC 5573066. PMID 28860733.
  93. ^ Kamburoglu G, Gumus K, Kadayifcilar S, Eldem B (May 2006). "Plasma homocysteine, vitamin B12 and folate levels in age-related macular degeneration". Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht von Graefes Archiv für Klinische und Experimentelle Ophthalmologie. 244 (5): 565–569. doi:10.1007/s00417-005-0108-2. PMID 16163497. S2CID 25236215.
  94. ^ Rochtchina E, Wang JJ, Flood VM, Mitchell P (February 2007). "Elevated serum homocysteine, low serum vitamin B12, folate, and age-related macular degeneration: the Blue Mountains Eye Study". American Journal of Ophthalmology. 143 (2): 344–346. doi:10.1016/j.ajo.2006.08.032. PMID 17258528.
  95. ^ Christen WG, Glynn RJ, Chew EY, Albert CM, Manson JE (February 2009). "Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women's Antioxidant and Folic Acid Cardiovascular Study". Archives of Internal Medicine. 169 (4): 335–341. doi:10.1001/archinternmed.2008.574. PMC 2648137. PMID 19237716.
  96. ^ Heuberger RA, Fisher AI, Jacques PF, Klein R, Klein BE, Palta M, et al. (October 2002). "Relation of blood homocysteine and its nutritional determinants to age-related maculopathy in the third National Health and Nutrition Examination Survey". The American Journal of Clinical Nutrition. 76 (4): 897–902. doi:10.1093/ajcn/76.4.897. PMID 12324306.
  97. ^ Morley JE, Vellas B, van Kan GA, Anker SD, Bauer JM, Bernabei R, et al. (June 2013). "Frailty consensus: a call to action". Journal of the American Medical Directors Association. 14 (6): 392–397. doi:10.1016/j.jamda.2013.03.022. PMC 4084863. PMID 23764209.
  98. ^ Vermeiren S, Vella-Azzopardi R, Beckwée D, Habbig AK, Scafoglieri A, Jansen B, et al. (December 2016). "Frailty and the Prediction of Negative Health Outcomes: A Meta-Analysis". Journal of the American Medical Directors Association. 17 (12): 1163.e1–1163.e17. doi:10.1016/j.jamda.2016.09.010. PMID 27886869.
  99. ^ Soysal P, Stubbs B, Lucato P, Luchini C, Solmi M, Peluso R, et al. (November 2016). "Inflammation and frailty in the elderly: A systematic review and meta-analysis". Ageing Research Reviews. 31: 1–8. doi:10.1016/j.arr.2016.08.006. hdl:10447/463258. PMID 27592340. S2CID 460021.
  100. ^ O'Leary F, Flood VM, Petocz P, Allman-Farinelli M, Samman S (June 2011). "B vitamin status, dietary intake and length of stay in a sample of elderly rehabilitation patients". The Journal of Nutrition, Health & Aging. 15 (6): 485–489. doi:10.1007/s12603-010-0330-4. PMID 21623471. S2CID 23887493.
  101. ^ Matteini AM, Walston JD, Fallin MD, Bandeen-Roche K, Kao WH, Semba RD, et al. (May 2008). "Markers of B-vitamin deficiency and frailty in older women". The Journal of Nutrition, Health & Aging. 12 (5): 303–308. doi:10.1007/BF02982659. PMC 2739594. PMID 18443711.
  102. ^ a b Hunt A, Harrington D, Robinson S (September 2014). "Vitamin B12 deficiency". BMJ. 349 (sep04 1): g5226. doi:10.1136/bmj.g5226. PMID 25189324. S2CID 28782021.
  103. ^ a b Quadros EV (January 2010). "Advances in the understanding of cobalamin assimilation and metabolism". British Journal of Haematology. 148 (2): 195–204. doi:10.1111/j.1365-2141.2009.07937.x. PMC 2809139. PMID 19832808.
  104. ^ a b Gröber U, Kisters K, Schmidt J (December 2013). "Neuroenhancement with vitamin B12-underestimated neurological significance". Nutrients. 5 (12): 5031–5045. doi:10.3390/nu5125031. PMC 3875920. PMID 24352086.
  105. ^ Holmes JM (December 15, 1956). "Cerebral Manifestations of Vitamin-B12 Deficiency". Br Med J. 2 (5006): 1394–1398. doi:10.1136/bmj.2.5006.1394. ISSN 0007-1447. PMC 2035923. PMID 13374343.
  106. ^ Ralapanawa DM, Jayawickreme KP, Ekanayake EM, Jayalath WA (September 2015). "B12 deficiency with neurological manifestations in the absence of anaemia". BMC Research Notes. 8 (1): 458. doi:10.1186/s13104-015-1437-9. PMC 4575440. PMID 26385097.
  107. ^ Rosenberg IH (June 2008). "Effects of folate and vitamin B12 on cognitive function in adults and the elderly". Food and Nutrition Bulletin. 29 (2 Suppl): S132–S142. doi:10.1177/15648265080292S118. PMID 18709888. S2CID 1509549.
  108. ^ Smith AD, Refsum H (February 2009). "Vitamin B-12 and cognition in the elderly". The American Journal of Clinical Nutrition. 89 (2): 707S–711S. doi:10.3945/ajcn.2008.26947D. PMID 19116332.
  109. ^ Lewis MS, Miller LS, Johnson MA, Dolce EB, Allen RH, Stabler SP (April 14, 2005). "Elevated methylmalonic acid is related to cognitive impairement in older adults enrolled in an elderly nutrition program". Journal of Nutrition for the Elderly. 24 (3): 47–65. doi:10.1300/J052v24n03_05. PMID 15911524. S2CID 37997967.
  110. ^ McCully KS (November 2007). "Homocysteine, vitamins, and vascular disease prevention". The American Journal of Clinical Nutrition. 86 (5): 1563S–1568S. doi:10.1093/ajcn/86.5.1563S. PMID 17991676.
  111. ^ Malouf R, Areosa Sastre A, et al. (The Cochrane Collaboration) (July 21, 2003). "Vitamin B12 for cognition". The Cochrane Database of Systematic Reviews (3). Chichester, UK: John Wiley & Sons, Ltd: CD004326. doi:10.1002/14651858.cd004326. PMID 12918012.
  112. ^ Vogiatzoglou A, Refsum H, Johnston C, Smith SM, Bradley KM, de Jager C, et al. (September 2008). "Vitamin B12 status and rate of brain volume loss in community-dwelling elderly". Neurology. 71 (11): 826–832. doi:10.1212/01.wnl.0000325581.26991.f2. PMID 18779510. S2CID 22192911.
  113. ^ Dhonukshe-Rutten RA, Pluijm SM, de Groot LC, Lips P, Smit JH, van Staveren WA (June 2005). "Homocysteine and vitamin B12 status relate to bone turnover markers, broadband ultrasound attenuation, and fractures in healthy elderly people". Journal of Bone and Mineral Research. 20 (6): 921–929. doi:10.1359/JBMR.050202. PMID 15883631. S2CID 11881415.
  114. ^ Tucker KL, Hannan MT, Qiao N, Jacques PF, Selhub J, Cupples LA, et al. (January 2005). "Low plasma vitamin B12 is associated with lower BMD: the Framingham Osteoporosis Study". Journal of Bone and Mineral Research. 20 (1): 152–158. doi:10.1359/JBMR.041018. PMID 15619681. S2CID 33994229.
  115. ^ Herrmann M, Peter Schmidt J, Umanskaya N, Wagner A, Taban-Shomal O, Widmann T, et al. (January 1, 2007). "The role of hyperhomocysteinemia as well as folate, vitamin B(6) and B(12) deficiencies in osteoporosis: a systematic review". Clinical Chemistry and Laboratory Medicine. 45 (12): 1621–1632. doi:10.1515/CCLM.2007.362. PMID 18067447. S2CID 7641257.
  116. ^ Morris MS, Jacques PF, Selhub J (August 2005). "Relation between homocysteine and B-vitamin status indicators and bone mineral density in older Americans". Bone. 37 (2): 234–242. doi:10.1016/j.bone.2005.04.017. PMID 15950558.
  117. ^ Carmel R, Lau KH, Baylink DJ, Saxena S, Singer FR (July 1988). "Cobalamin and osteoblast-specific proteins". The New England Journal of Medicine. 319 (2): 70–75. doi:10.1056/NEJM198807143190202. PMID 3260008.
  118. ^ Kim GS, Kim CH, Park JY, Lee KU, Park CS (December 1996). "Effects of vitamin B12 , on cell proliferation and cellular alkaline phosphatase activity in human bone marrow stromal osteoprogenitor cells and UMR106 osteoblastic cells". Metabolism. 45 (12): 1443–1446. doi:10.1016/S0026-0495(96)90171-7. PMID 8969275.
  119. ^ Herrmann M, Umanskaya N, Traber L, Schmidt-Gayk H, Menke W, Lanzer G, et al. (January 1, 2007). "The effect of B-vitamins on biochemical bone turnover markers and bone mineral density in osteoporotic patients: a 1-year double blind placebo controlled trial". Clinical Chemistry and Laboratory Medicine. 45 (12): 1785–1792. doi:10.1515/CCLM.2007.352. PMID 18020969. S2CID 36679018.
  120. ^ Green TJ, McMahon JA, Skeaff CM, Williams SM, Whiting SJ (February 2007). "Lowering homocysteine with B vitamins has no effect on biomarkers of bone turnover in older persons: a 2-y randomized controlled trial". The American Journal of Clinical Nutrition. 85 (2): 460–464. doi:10.1093/ajcn/85.2.460. PMID 17284744.
  121. ^ Allen LH, Rosenberg IH, Oakley GP, Omenn GS (March 2010). "Considering the case for vitamin B12 fortification of flour". Food and Nutrition Bulletin. 31 (1 Suppl): S36–S46. doi:10.1177/15648265100311S104. PMID 20629351. S2CID 25738026.
  122. ^ Banka S, Ryan K, Thomson W, Newman WG (June 2011). "Pernicious anemia - genetic insights". Autoimmunity Reviews. 10 (8): 455–459. doi:10.1016/j.autrev.2011.01.009. ISSN 1873-0183. PMID 21296191.
  123. ^ Green R, Allen LH, Bjørke-Monsen AL, Brito A, Guéant JL, Miller JW, et al. (June 2017). "Vitamin B12 deficiency". Nature Reviews. Disease Primers. 3: 17040. doi:10.1038/nrdp.2017.40. PMID 28660890. S2CID 205479529.
  124. ^ Rojas Hernandez CM, Oo TH (March 2015). "Advances in mechanisms, diagnosis, and treatment of pernicious anemia". Discovery Medicine. 19 (104): 159–168. PMID 25828519.
  125. ^ Marzinotto I, Dottori L, Baldaro F, Dilaghi E, Brigatti C, Bazzigaluppi E, et al. (2021). "Intrinsic factor autoantibodies by luminescent immuno-precipitation system in patients with corpus atrophic gastritis". Journal of Translational Autoimmunity. 4: 100131. doi:10.1016/j.jtauto.2021.100131. ISSN 2589-9090. PMC 8716657. PMID 35005595.
  126. ^ a b "Blind loop syndrome: MedlinePlus Medical Encyclopedia". medlineplus.gov. Archived from the original on July 28, 2018. Retrieved February 16, 2022.
  127. ^ a b c Baik HW, Russell RM (1999). "Vitamin B12 deficiency in the elderly". Annual Review of Nutrition. 19: 357–377. doi:10.1146/annurev.nutr.19.1.357. PMID 10448529.
  128. ^ Lam JR, Schneider JL, Zhao W, Corley DA (December 2013). "Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency". JAMA. 310 (22): 2435–2442. doi:10.1001/jama.2013.280490. PMID 24327038.
  129. ^ "Illness and Symptoms | Giardia | Parasites | CDC". www.cdc.gov. March 2, 2021. Retrieved February 18, 2022.
  130. ^ Ulasoglu C, Temiz HE, Sağlam ZA (2019). "The Relation of Cytotoxin-Associated Gene-A Seropositivity with Vitamin B12 Deficiency in Helicobacter pylori-Positive Patients". BioMed Research International. 2019: 1450536. doi:10.1155/2019/1450536. PMC 6925818. PMID 31886171.
  131. ^ Ting RZ, Szeto CC, Chan MH, Ma KK, Chow KM (October 2006). "Risk factors of vitamin B(12) deficiency in patients receiving metformin". Archives of Internal Medicine. 166 (18): 1975–1979. doi:10.1001/archinte.166.18.1975. PMID 17030830.
  132. ^ Yeomans ND, Hanson RG, Smallwood RA, Mihaly GW, Louis WJ (July 1982). "Effect of chronic ranitidine treatment on secretion of intrinsic factor". British Medical Journal. 285 (6337): 264. doi:10.1136/bmj.285.6337.264. PMC 1499627. PMID 6124297.
  133. ^ Kondo H, Osborne ML, Kolhouse JF, Binder MJ, Podell ER, Utley CS, et al. (May 1981). "Nitrous oxide has multiple deleterious effects on cobalamin metabolism and causes decreases in activities of both mammalian cobalamin-dependent enzymes in rats". The Journal of Clinical Investigation. 67 (5): 1270–1283. doi:10.1172/JCI110155. PMC 370693. PMID 6112240.
  134. ^ Croft MT, Lawrence AD, Raux-Deery E, Warren MJ, Smith AG (November 2005). "Algae acquire vitamin B12 through a symbiotic relationship with bacteria". Nature. 438 (7064): 90–93. Bibcode:2005Natur.438...90C. doi:10.1038/nature04056. PMID 16267554. S2CID 4328049.
  135. ^ Rasmussen SA, Fernhoff PM, Scanlon KS (January 2001). "Vitamin B12 deficiency in children and adolescents". The Journal of Pediatrics. 138 (1): 10–17. doi:10.1067/mpd.2001.112160. PMID 11148506.
  136. ^ Voet D, Voet JG (2010). Biochemistry. New York: J. Wiley & Sons. p. 957. ISBN 978-0-470-57095-1.
  137. ^ Kazuhiro Y (2013). "Cobalt: Its Role in Health and Disease". In Sigel A, Sigel H, Sigel RK (eds.). Interrelations between Essential Metal Ions and Human Diseases. Metal Ions in Life Sciences. Vol. 13. Springer. pp. 295–320. doi:10.1007/978-94-007-7500-8_9. ISBN 978-94-007-7499-5. PMID 24470095.
  138. ^ Shane B, Stokstad EL (1985). "Vitamin B12-folate interrelationships". Annual Review of Nutrition. 5: 115–141. doi:10.1146/annurev.nu.05.070185.000555. PMID 3927946.
  139. ^ "Vitamin B12 / Pathophysiology Text". LifeSave.org. p. 215. Archived from the original on February 6, 2013. Retrieved December 31, 2013.
  140. ^ a b c d Snow CF (June 1999). "Laboratory diagnosis of vitamin B12 and folate deficiency: a guide for the primary care physician". Archives of Internal Medicine. 159 (12): 1289–1298. doi:10.1001/archinte.159.12.1289. PMID 10386505.
  141. ^ Herbert V, Colman N, Palat D, Manusselis C, Drivas G, Block E, et al. (November 1984). "Is there a "gold standard" for human serum vitamin B12 assay?". The Journal of Laboratory and Clinical Medicine. 104 (5): 829–841. ISSN 0022-2143. PMID 6387014.
  142. ^ Hvas AM, Nexo E (November 2006). "Diagnosis and treatment of vitamin B12 deficiency--an update". Haematologica. 91 (11): 1506–1512. PMID 17043022.
  143. ^ Devalia V, Hamilton MS, Molloy AM (August 2014). "Guidelines for the diagnosis and treatment of cobalamin and folate disorders". British Journal of Haematology. 166 (4). Wiley: 496–513. doi:10.1111/bjh.12959. PMID 24942828. S2CID 5772424.
  144. ^ Lindenbaum J, Healton EB, Savage DG, Brust JC, Garrett TJ, Podell ER, et al. (June 1988). "Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis". The New England Journal of Medicine. 318 (26): 1720–1728. doi:10.1056/NEJM198806303182604. PMID 3374544.
  145. ^ Kliegman RM, Nelson WE, eds. (2016). Nelson textbook of pediatrics: get full access and more at ExpertConsult.com (20. ed., [internat. ed.] ed.). Philadelphia, Pa: Elsevier, Saunders. ISBN 978-1-4557-7566-8.
  146. ^ de Sain-van der Velden MG, van der Ham M, Jans JJ, Visser G, Prinsen HC, Verhoeven-Duif NM, et al. (2016). Morava E, Baumgartner M, Patterson M, Rahman S (eds.). "A New Approach for Fast Metabolic Diagnostics in CMAMMA". JIMD Reports. 30. Berlin, Heidelberg: Springer Berlin Heidelberg: 15–22. doi:10.1007/8904_2016_531. ISBN 978-3-662-53680-3. PMC 5110436. PMID 26915364.
  147. ^ Devalia V (August 2006). "Diagnosing vitamin B-12 deficiency on the basis of serum B-12 assay". BMJ. 333 (7564): 385–386. doi:10.1136/bmj.333.7564.385. PMC 1550477. PMID 16916826.
  148. ^ "What is the role of bone marrow aspiration in the diagnosis of megaloblastic anemia?". www.medscape.com. Retrieved October 15, 2021.
  149. ^ Nickoloff E (1988). "Schilling test: physiologic basis for and use as a diagnostic test". Critical Reviews in Clinical Laboratory Sciences. 26 (4): 263–276. doi:10.3109/10408368809105892. PMID 3077032.
  150. ^ "Vitamin B12 or folate deficiency anaemia – Diagnosis". nhs.uk. October 20, 2017. Retrieved November 12, 2022.
  151. ^ Goodman M, Chen XH, Darwish D (October 1996). "Are U.S. lower normal B12 limits too low?". Journal of the American Geriatrics Society. 44 (10): 1274–1275. doi:10.1111/j.1532-5415.1996.tb01389.x. PMID 8856015. S2CID 34014860.
  152. ^ Wolffenbuttel BH, Wouters HJ, Heiner-Fokkema MR, van der Klauw MM (June 2019). "The Many Faces of Cobalamin (Vitamin B12) Deficiency". Mayo Clinic Proceedings: Innovations, Quality & Outcomes. 3 (2): 200–214. doi:10.1016/j.mayocpiqo.2019.03.002. ISSN 2542-4548. PMC 6543499. PMID 31193945.
  153. ^ Malouf R, Grimley Evans J (October 8, 2008). "Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people". The Cochrane Database of Systematic Reviews (4): CD004514. doi:10.1002/14651858.CD004514.pub2. ISSN 1469-493X. PMID 18843658.
  154. ^ "Diagnosis and treatment pitfalls – B12 institute". Retrieved April 5, 2023.
  155. ^ de Benoist B (June 2008). "Conclusions of a WHO Technical Consultation on folate and vitamin B12 deficiencies". Food and Nutrition Bulletin. 29 (2 Suppl): S238–S244. doi:10.1177/15648265080292S129. PMID 18709899.
  156. ^ Stabler SP, Allen RH (July 14, 2004). "Vitamin B12 deficiency as a worldwide problem". Annual Review of Nutrition. 24 (1): 299–326. doi:10.1146/annurev.nutr.24.012003.132440. PMID 15189123.
  157. ^ a b Pfeiffer CM, Johnson CL, Jain RB, Yetley EA, Picciano MF, Rader JI, et al. (September 2007). "Trends in blood folate and vitamin B-12 concentrations in the United States, 1988 2004". The American Journal of Clinical Nutrition. 86 (3): 718–727. doi:10.1093/ajcn/86.3.718. PMID 17823438.
  158. ^ a b Pfeiffer CM, Caudill SP, Gunter EW, Osterloh J, Sampson EJ (August 2005). "Biochemical indicators of B vitamin status in the US population after folic acid fortification: results from the National Health and Nutrition Examination Survey 1999–2000". The American Journal of Clinical Nutrition. 82 (2): 442–450. doi:10.1093/ajcn/82.2.442. PMID 16087991.
  159. ^ Ruston D, Henderson L, Gregory J, Bates CJ, Prentice A, Birch M, et al. (2004). "National Diet and Nutrition Survey: Adults Aged 19 to 64 Years". Nutritional Status (Anthropometry and Blood Analytes), Blood Pressure and Physical Activity. 4. The Stationery Office.
  160. ^ Smithers G, Finch S, Doyle W, Lowe C, Bates CJ, Prentice A, et al. (June 1998). "The National Diet and Nutrition Survey: people aged 65 years and over". Nutrition & Food Science. 98 (3): 133–134. doi:10.1108/00346659810209791.
  161. ^ a b Bates B, Prentice A, Bates C, Swan G (2011). National Diet and Nutrition Survey: Headline Results from Years 1, 2 and 3 (combined) of the Rolling Programme 2008/09 – 2010/11 (Report).
  162. ^ Thamm M, Mensink GB, Thierfelder W (December 1999). "[Folic acid intake of women in childbearing age]". Gesundheitswesen (in German). 61 Spec No: S207–S212. PMID 10726422.
  163. ^ McLean E, de Benoist B, Allen LH (June 2008). "Review of the magnitude of folate and vitamin B12 deficiencies worldwide". Food and Nutrition Bulletin. 29 (2 Suppl): S38–S51. doi:10.1177/15648265080292S107. PMID 18709880. S2CID 5562175.
  164. ^ a b García-Casal MN, Osorio C, Landaeta M, Leets I, Matus P, Fazzino F, et al. (September 2005). "High prevalence of folic acid and vitamin B12 deficiencies in infants, children, adolescents and pregnant women in Venezuela". European Journal of Clinical Nutrition. 59 (9): 1064–1070. doi:10.1038/sj.ejcn.1602212. PMID 16015269. S2CID 2453114.
  165. ^ Cuevas-Nasu L, Mundo-Rosas V, Shamah-Levy T, Méndez-Gómez Humaran I, Avila-Arcos MA, Rebollar-Campos M, et al. (April 2012). "Prevalence of folate and vitamin B12 deficiency in Mexican children aged 1 to 6 years in a population-based survey". Salud Publica de Mexico. 54 (2): 116–124. doi:10.1590/S0036-36342012000200007. PMID 22535170.
  166. ^ Laillou A, Pham TV, Tran NT, Le HT, Wieringa F, Rohner F, et al. (April 17, 2012). Smith B (ed.). "Micronutrient deficits are still public health issues among women and young children in Vietnam". PLOS ONE. 7 (4): e34906. Bibcode:2012PLoSO...734906L. doi:10.1371/journal.pone.0034906. PMC 3328495. PMID 22529954.
  167. ^ Green TJ, Venn BJ, Skeaff CM, Williams SM (February 2005). "Serum vitamin B12 concentrations and atrophic gastritis in older New Zealanders". European Journal of Clinical Nutrition. 59 (2): 205–210. doi:10.1038/sj.ejcn.1602059. PMID 15483636. S2CID 31599027.
  168. ^ Taneja S, Bhandari N, Strand TA, Sommerfelt H, Refsum H, Ueland PM, et al. (November 2007). "Cobalamin and folate status in infants and young children in a low-to-middle income community in India". The American Journal of Clinical Nutrition. 86 (5): 1302–1309. doi:10.1093/ajcn/86.5.1302. PMID 17991639.
  169. ^ Refsum H, Yajnik CS, Gadkari M, Schneede J, Vollset SE, Orning L, et al. (August 2001). "Hyperhomocysteinemia and elevated methylmalonic acid indicate a high prevalence of cobalamin deficiency in Asian Indians". The American Journal of Clinical Nutrition. 74 (2): 233–241. doi:10.1093/ajcn/74.2.233. PMID 11470726.
  170. ^ Siekmann JH, Allen LH, Bwibo NO, Demment MW, Murphy SP, Neumann CG (November 2003). "Kenyan school children have multiple micronutrient deficiencies, but increased plasma vitamin B-12 is the only detectable micronutrient response to meat or milk supplementation". The Journal of Nutrition. 133 (11 Suppl 2): 3972S–3980S. doi:10.1093/jn/133.11.3972S. PMID 14672298.
  171. ^ Smith AD, Warren MJ, Refsum H (2018). "Chapter Six – Vitamin B12". In Eskin NA (ed.). Advances in Food and Nutrition Research. Vol. 83. Academic Press. pp. 215–279. doi:10.1016/bs.afnr.2017.11.005. ISBN 978-0-12-811803-0. PMID 29477223.
  172. ^ a b c Greer JP (2014). Wintrobe's Clinical Hematology Thirteenth Edition. Philadelphia, PA: Wolters Kluwer/Lippincott Williams & Wilkins. ISBN 978-1-4511-7268-3. Chapter 36: Megaloblastic anemias: disorders of impaired DNA synthesis by Ralph Carmel
  173. ^ "George H. Whipple – Biographical". www.nobelprize.org. Retrieved October 10, 2017.
  174. ^ The Nobel Prize in Physiology or Medicine 1934, Nobelprize.org, Nobel Media AB 2014. Retrieved December 2, 2015.
  175. ^ a b c McDowell LR (2008). Vitamins in Animal and Human Nutrition (2nd ed.). Hoboken: John Wiley & Sons. p. 525. ISBN 978-0-470-37668-3. Archived from the original on September 8, 2017.
  176. ^ "Soils". Waikato University. Archived from the original on January 25, 2012. Retrieved January 16, 2012.
  177. ^ "Hedley Ralph Marston 1900–1965". Biographical Memoirs of Deceased Fellows. Australian Academy of Science. Archived from the original on December 6, 2006. Retrieved May 12, 2013.

Further reading

[edit]
  • Greer JP (2014). Wintrobe's Clinical Hematology Thirteenth Edition. Philadelphia, PA: Wolters Kluwer/Lippincott Williams & Wilkins. ISBN 978-1-4511-7268-3. Chapter 36: Megaloblastic anemias: disorders of impaired DNA synthesis by Ralph Carmel. The gold standard of clinical hematology textbooks since 1942.
  • Hunt A, Harrington D, Robinson S (September 2014). "Vitamin B12 deficiency". BMJ. 349: g5226. doi:10.1136/bmj.g5226. PMID 25189324. S2CID 28782021.
  • Pacholok SM, Stuart JJ (2011). Could It Be B12?: An Epidemic of Misdiagnoses. Fresno, CA: Linden Publishing. ISBN 978-1-61035-065-5.
  • Hooper M (2012). Pernicious Anaemia: The Forgotten Disease – the causes and consequences of Vitamin B12 Deficiency. London: Hammersmith Press. ISBN 978-1-78161-004-6.
Retrieved from "https://wiki.riteme.site/w/index.php?title=Vitamin_B12_deficiency&oldid=1262244369"